Thermal analysis evaluation testing for active pharmaceutical ingredients (APIs) is a critical component of pharmaceutical development, providing essential data on melting behavior, polymorphism, hydrate formation, thermal stability, and purity. Techniques such as differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) help manufacturers characterize drug substances, support regulatory submissions, and ensure consistent product quality. This article outlines the principles, sample types, testing items, methods, and applications of API thermal analysis performed by accredited third-party laboratories.
Technical Overview
Thermal analysis refers to a family of analytical techniques that measure the physical and chemical properties of a substance as a function of temperature or time under a controlled temperature program. For active pharmaceutical ingredients (APIs), thermal analysis is one of the most informative and widely used characterization approaches because the solid-state form of a drug substance directly influences its solubility, bioavailability, stability, and manufacturability.
The two core techniques applied in API evaluation are differential scanning calorimetry (DSC), which measures heat flow associated with thermal transitions such as melting, crystallization, and glass transition, and thermogravimetric analysis (TGA), which monitors mass change caused by dehydration, desolvation, or decomposition. Complementary methods, including hot-stage microscopy and evolved gas analysis, may be combined with DSC and TGA to provide a complete solid-state picture of the material.
Thermal analysis data support polymorph screening, salt and co-crystal selection, amorphous content quantification, drug-excipient compatibility assessment, and stability investigations. Studies are typically conducted in accredited third-party laboratories in accordance with internationally recognized standards from organizations such as ISO, ASTM, and GB, and in alignment with current pharmacopoeial expectations for drug substance characterization.
Testing Samples
Crystalline Drug Substances
Crystalline APIs are the most common samples submitted for thermal analysis. DSC curves reveal melting point, melting range, enthalpy of fusion, and possible solid-solid transitions, which serve as fingerprints of the crystalline form and support batch-to-batch consistency verification.
Amorphous and Semi-Crystalline Materials
Amorphous APIs and amorphous solid dispersions exhibit glass transition events that can be detected and quantified by DSC, including modulated DSC. Thermal analysis also detects recrystallization upon heating, which indicates physical instability of the amorphous form.
Hydrates and Solvates
Hydrated or solvated drug substances lose stoichiometric amounts of water or solvent at characteristic temperatures. TGA quantifies the mass loss, confirming the hydrate or solvate stoichiometry, while DSC identifies the associated endothermic events.
Salts, Co-Crystals, and Polymorphic Forms
Different polymorphs, salts, and co-crystals of the same molecule display distinct thermal signatures. Comparative DSC and TGA profiles are used to distinguish forms, detect mixtures of forms, and evaluate interconversion behavior under thermal stress.
API-Excipient Compatibility Mixtures
Binary or multi-component blends of API with excipients are heated to detect interactions such as shifted melting peaks, new endothermic or exothermic events, or accelerated degradation, providing early guidance for formulation design.
Testing Items
Typical testing items covered in an API thermal analysis evaluation program include the following:
- Melting point and melting range determination
- Enthalpy of fusion (heat of melting) measurement
- DSC purity estimation for high-purity crystalline compounds
- Glass transition temperature (Tg) determination
- Crystallization temperature and crystallization enthalpy
- Solid-solid polymorphic transition detection
- Crystallinity and amorphous content assessment
- Dehydration and desolvation mass loss quantification
- Residual water and residual solvent content estimation
- Thermal decomposition onset temperature
- Specific heat capacity measurement
- Drug-excipient compatibility screening
Testing Methods
DSC experiments are generally performed using heat-flux or power-compensation instruments calibrated according to recognized procedures such as ASTM E967 (temperature calibration) and ASTM E968 (enthalpy calibration). Glass transition temperatures are determined in line with ASTM E1356, while ISO 11357 series methods are frequently referenced for DSC measurement conditions. Samples of typically 2 to 10 mg are sealed in aluminum pans and heated under a purge of dry nitrogen at rates commonly between 2 and 10 °C/min. Hermetic pans are used when volatile content must be retained, whereas open or pierced pans allow moisture and solvent release to be observed.
TGA experiments follow approaches consistent with ASTM E1131 for compositional analysis and ASTM E1582 for temperature calibration. The sample is heated in a controlled atmosphere while mass is continuously recorded, allowing the analyst to distinguish adsorbed moisture, lattice solvent, and true decomposition steps. Variable atmosphere studies, comparing inert nitrogen with oxidative air conditions, further characterize the degradation pathway.
Modulated DSC (MDSC) may be applied to separate reversing events such as the glass transition from non-reversing events such as evaporation or relaxation enthalpy, which is particularly valuable for amorphous dispersions. Where required, hot-stage microscopy is added to visually confirm melting, sublimation, or polymorphic transformation events, and results are interpreted against the specific acceptance criteria agreed with the sponsor.
Applications
Thermal analysis evaluation of APIs supports multiple stages of the pharmaceutical product lifecycle:
- Solid-form screening and selection: comparing polymorphs, hydrates, salts, and co-crystals to select the developable form with adequate stability and solubility.
- Pre-formulation development: assessing drug-excipient compatibility and identifying physical instability risks before formulation commitment.
- Process development support: evaluating the effect of drying, milling, granulation, and spray drying on the solid-state form of the API.
- Stability studies: detecting form conversion, moisture uptake, or loss of crystallinity during storage under accelerated and long-term conditions.
- Quality control and release testing: using melting behavior and thermal fingerprints as identity and consistency indicators for incoming API batches.
- Regulatory submission support: generating the solid-state characterization data expected in drug substance sections of regulatory filings.
- Reference standard and impurity profiling: estimating absolute purity and confirming the thermal properties of working standards.
FAQ
How much sample is required for API thermal analysis?
Both DSC and TGA are micro-scale techniques. Typically, only 2 to 10 mg of material is required per experiment. Because several runs, including replicates and method variations, may be needed for a complete evaluation, laboratories generally request 50 to 200 mg of the API to ensure a robust study design.
Can DSC and TGA distinguish between polymorphs?
Yes. Different polymorphs usually exhibit distinct melting points, melting enthalpies, or solid-solid transition temperatures in DSC curves, while TGA differentiates forms by their dehydration or desolvation behavior. Low-level polymorph impurities in a matrix can be detected when the detection limit of the instrument and the thermal separation of the forms are adequate.
How is the purity of an API estimated by DSC?
The Van't Hoff-based DSC purity method uses the shape depression of the melting endotherm to calculate mole percent purity. It is applicable to high-purity crystalline compounds that melt without decomposition and do not form solid solutions, and results are typically reliable above approximately 98 mole percent purity.
What is the difference between DSC and TGA results?
DSC measures heat flow and detects energetic events such as melting, crystallization, and glass transition, whereas TGA measures mass change and identifies processes such as moisture loss, solvent loss, and decomposition. The two techniques are complementary, and running both on the same sample allows ambiguous endothermic events, such as melting versus desolvation, to be correctly assigned.
How should API samples be prepared and shipped for thermal analysis?
Samples should be stored and shipped in tightly sealed containers to prevent moisture uptake or solvent loss that could alter the solid-state form. Information on known polymorphs, hydrate status, expected thermal events, and safety handling requirements should accompany the submission so that the laboratory can select appropriate pans, atmospheres, and temperature programs.
What turnaround time is typical for a thermal analysis evaluation?
Standard DSC and TGA measurements can usually be completed within a few working days after sample receipt. Comprehensive programs involving polymorph comparison, method optimization, or compatibility panels with multiple excipients require additional time, and the laboratory will confirm the schedule based on the agreed study scope.